• Urolithin A: Mitochondrial Biogenesis and Glutamine Metaboli

  2026-04-25

  Explore how Urolithin A, a gut microbiota-derived metabolite, advances mitochondrial biogenesis research and modulates glutamine metabolism. This article uniquely dissects its mechanistic roles and protocol implications for liver fibrosis and cellular studies.

• Uremic Toxins Alter Protein Adsorption on PEO-Coated Surface

  2026-04-24

  This study demonstrates that common uremic toxins, including 4-ethylphenyl sulfate, significantly increase plasma protein adsorption on poly(ethylene oxide) (PEO)-modified surfaces, overriding the protective effects of PEO chain density. These findings highlight the need to account for disease-specific blood composition in biomaterial design, particularly for patients with renal dysfunction.

• KR-12 Human Antimicrobial Peptide: Workflows & Biofilm Contr

  2026-04-24

  KR-12, the smallest LL-37 fragment, offers targeted antimicrobial and anti-biofilm action against multidrug-resistant pathogens with low mammalian cytotoxicity. This guide translates bench research into actionable protocols and troubleshooting strategies for maximizing KR-12's research impact.

• Thermal Shift Assays Reveal Ligands for Bacterial Sensor Pro

  2026-04-23

  This review synthesizes advances in using thermal shift assays to identify ligands for bacterial sensor proteins, detailing technical refinements and experimental considerations. The findings enhance understanding of bacterial signaling and offer methodological guidance for high-throughput ligand discovery and target validation.

• HMGB1 as an Early Serum Biomarker for Diabetic Nephropathy

  2026-04-23

  Peng et al. (2024) identify HMGB1 as a promising noninvasive serum biomarker for early detection and monitoring of diabetic nephropathy progression using quantitative proteomics and robust validation. These findings have significant implications for improving early diagnosis and risk stratification in diabetic kidney disease, potentially informing future clinical applications.

• Prevotella copri Promotes Breast Cancer via IPyA Depletion a

  2026-04-22

  This study reveals that enrichment of Prevotella copri in the gut microbiota of breast cancer patients leads to the depletion of the intrinsic metabolite indole-3-pyruvic acid (IPyA), which in turn accelerates tumor progression by inactivating AMPK through UHRF1-mediated regulation. These findings underscore a novel microbiota-cancer axis and highlight metabolic pathways as potential therapeutic targets.

• Estrogen Drives PTC Progression via ERα/KRT19 Signaling Axis

  2026-04-22

  This study elucidates how estrogen promotes papillary thyroid carcinoma (PTC) proliferation, migration, and invasion through the ERα/KRT19 signaling axis. Integrating transcriptomic and functional assays, the research advances understanding of estrogen-driven PTC mechanisms and highlights KRT19 as a potential molecular target.

• Tofacitinib Citrate (CP-690550): Advanced Immune Regulation

  2026-04-21

  Tofacitinib citrate (CP-690550 citrate) empowers precise, reproducible dissection of JAK-STAT signaling and immune cell modulation in inflammatory disorder research. This guide delivers actionable protocol enhancements, comparative data, and troubleshooting strategies, grounded in recent cardiovascular safety findings and best-in-class sourcing from APExBIO.

• (-)-Arctigenin: MEK1 Inhibitor Workflows for Tumor Microenvi

  2026-04-21

  Leverage (-)-Arctigenin’s nanomolar MEK1 and iNOS inhibition to dissect NF-κB-driven signaling in complex tumor microenvironment models. APExBIO’s high-purity preparation empowers reproducible anti-inflammatory and metastatic breast cancer assays where pathway specificity and workflow reliability are paramount.

• Vitamin C in Organoid Research: Mechanisms and Strategy Forw

  2026-04-20

  This article explores the mechanistic, translational, and strategic applications of high-purity Vitamin C (CAS 50-81-7) in advanced organoid models, with a focus on anticancer and antiviral research. Drawing on recent HEV organoid studies and APExBIO’s high-quality reagent, we provide actionable guidance for researchers at the frontier of experimental medicine.

• Caspase-4 Colorimetric Assay Kit: Quantitative Enzyme Detect

  2026-04-20

  The Caspase-4 Colorimetric Assay Kit enables rapid, quantitative detection of LEVD-dependent caspase-4 activity. This colorimetric caspase assay delivers reproducible results for pyroptosis and inflammasome research, supporting both mechanistic studies and biomarker discovery.

• Distinct Vascular Effects of JAK Inhibitors in Endothelial I

  2026-04-19

  This study systematically compares the vascular effects of multiple JAK inhibitors, including tofacitinib citrate, under inflammatory conditions relevant to rheumatoid arthritis. The findings reveal nuanced differences in cytokine modulation and endothelial apoptosis, emphasizing the importance of inhibitor specificity when modeling cardiovascular risks in immune regulation research.

• HRP Goat Anti-Rabbit IgG (H+L) Antibody: Technical Guidance

  2026-04-18

  The HRP Goat Anti-Rabbit IgG (H+L) Antibody (SKU K1223) provides reliable secondary antibody detection in workflows such as Western blot, ELISA, and immunohistochemistry where rabbit IgG primaries are used. Its affinity-purified, HRP-conjugated format delivers robust signal amplification while minimizing cross-reactivity. This reagent is not suitable for diagnostic or therapeutic applications and should not be used outside the specified research contexts.

• Thermal Shift Assays for Ligand Discovery in Bacterial Senso

  2026-04-17

  This review synthesizes advances in using thermal shift assays to uncover the ligand-binding profiles of bacterial sensor proteins. The findings reveal new strategies for target identification, highlight methodological rigor, and suggest practical pathways for screening bioactive compounds in pathway analysis and drug discovery.

• Distinct Mechanisms of Chuanxiong Cortex and Pith in CHD The

  2026-04-16

  This study uses SPME-GC×GC-MS and network pharmacology to reveal the distinct bioactive components and molecular pathways of Chuanxiong’s rhizome cortex and pith in coronary heart disease (CHD) prevention. The findings advance understanding of tissue-specific compound distribution and highlight implications for optimizing traditional herbal interventions.

16007 records 1/1068 page Next 12345 下5页 Last page